GB1125675A - Stable ascorbic acid composition and process for preparing the same - Google Patents

Stable ascorbic acid composition and process for preparing the same

Info

Publication number
GB1125675A
GB1125675A GB468867A GB468867A GB1125675A GB 1125675 A GB1125675 A GB 1125675A GB 468867 A GB468867 A GB 468867A GB 468867 A GB468867 A GB 468867A GB 1125675 A GB1125675 A GB 1125675A
Authority
GB
United Kingdom
Prior art keywords
ascorbic acid
preparing
same
acid composition
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB468867A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of GB1125675A publication Critical patent/GB1125675A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GB468867A 1966-02-10 1967-01-31 Stable ascorbic acid composition and process for preparing the same Expired GB1125675A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP738966 1966-02-10

Publications (1)

Publication Number Publication Date
GB1125675A true GB1125675A (en) 1968-08-28

Family

ID=11664555

Family Applications (1)

Application Number Title Priority Date Filing Date
GB468867A Expired GB1125675A (en) 1966-02-10 1967-01-31 Stable ascorbic acid composition and process for preparing the same

Country Status (4)

Country Link
BE (1) BE693865A (de)
DE (1) DE1618577B2 (de)
FR (1) FR1510731A (de)
GB (1) GB1125675A (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000048A1 (en) * 1985-07-11 1987-01-15 Ferris Épito^"Ipari Szövetkezeti Közös Vállalat Pharmaceutical compositions and alimentary products for human comsumption for the treatment and/or prevention of diseases caused by free radical reactions and a process for the inhibition of free radical reactions in the human organism
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
CN100346782C (zh) * 2004-05-21 2007-11-07 北京京卫信康医药科技发展有限公司 一种含氨基酸的维生素c组合物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521429B1 (fr) * 1982-02-15 1988-10-28 Mayoly Spindler Laboratoires Nouvelles compositions a effet antiasthenique puissant a base de sels doubles de l'acide ascorbique et d'un diacide amine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000048A1 (en) * 1985-07-11 1987-01-15 Ferris Épito^"Ipari Szövetkezeti Közös Vállalat Pharmaceutical compositions and alimentary products for human comsumption for the treatment and/or prevention of diseases caused by free radical reactions and a process for the inhibition of free radical reactions in the human organism
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US6013632A (en) * 1997-01-13 2000-01-11 Emory University Compounds and their combinations for the treatment of influenza infection
US6107281A (en) * 1997-01-13 2000-08-22 Nutri-Quest, Inc. Compounds and their combinations for the treatment of influenza infection
CN100346782C (zh) * 2004-05-21 2007-11-07 北京京卫信康医药科技发展有限公司 一种含氨基酸的维生素c组合物

Also Published As

Publication number Publication date
FR1510731A (fr) 1968-01-19
DE1618577B2 (de) 1973-02-08
BE693865A (de) 1967-07-17
DE1618577A1 (de) 1972-02-24
DE1618577C3 (de) 1973-09-13

Similar Documents

Publication Publication Date Title
MY102473A (en) Purine derivates and their pharmaceutical use
GB1453616A (en) Process for producing a therapeutic composition
ES419619A1 (es) Procedimiento para remineralizar una sub-superficie desmi- neralizada de un diente.
GB1125675A (en) Stable ascorbic acid composition and process for preparing the same
GB1145512A (en) Method for isolating tryptophan
JPS5328960A (en) Nitration treatment
JPS5319999A (en) Production of phosphate and ammonium chloride
GB1428348A (en) Method of producing triaminoguanidine nitrate
GB1344651A (en) Purification of commercial grade phsophoric acid
GB1301555A (de)
GB1499764A (en) Polypeptides
GB1490290A (en) Preparation of penicillanic acid derivatives
GB1291678A (en) L-dopa and derivatives
GB1294233A (en) Systemic miticide and a method for controlling mites
GB1053177A (de)
GB1041408A (en) Improvements in or relating to the production of sodium bicarbonate
GB1178905A (en) Mixed Crystals of Glutamine and Inosinic Acid Derivatives
GB1268292A (en) 2-furfurylthioinosine and derivatives thereof
GB1326269A (en) Basic aminoacid salts of tocopherylsuccinate and method of making same
GB1171244A (en) Purification of Flavine Adenine Dinucleotide
GB1491679A (en) Pharmaceutical compositions
GB1154926A (en) Basic Amino Acid Succinates and their use in Seasonings
GB1253018A (de)
SE433363B (sv) Fosfateringsforfarande
GB1134516A (en) Antiviral compositions and treatment